Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Drug-eluting stent thrombosis in the treatment of chronic total coronary occlusions: incidence, presentation and related factors. Data from the CIBELES trial.
Arroyo-Úcar E, Moreno R, García E, Teles R, Rumoroso JR, Carvalho HC, Goicolea FJ, Moreu J, Mauri J, Sabaté M, Mainar V, Patricio L, Valdés M, Fernández-Vázquez F, Sánchez-Recalde A, Galeote G, Jimenez-Valero S, Almeida M, López de Sa E, Calvo L, Plaza I, Lopez-Sendón JL, Martín JL; CIBELES investigators. Arroyo-Úcar E, et al. Among authors: goicolea fj. Rev Port Cardiol. 2015 Mar;34(3):193-9. doi: 10.1016/j.repc.2014.08.026. Epub 2015 Feb 14. Rev Port Cardiol. 2015. PMID: 25686520 Free article. Clinical Trial.
A randomised comparison between everolimus-eluting stent and sirolimus-eluting stent in chronic coronary total occlusions. Rationale and design of the CIBELES (non-acute Coronary occlusion treated by EveroLimus-Eluting Stent) trial.
Moreno R, Garcia E, Teles RC, Almeida MS, Carvalho HC, Sabate M, Martin-Reyes R, Rumoroso JR, Galeote G, Goicolea FJ, Moreu J, Mainar V, Mauri J, Ferreira R, Valdes M, Perez de Prado A, Martin-Yuste V, Jimenez-Valero S, Sanchez-Recalde A, Calvo L, Lopez de Sa E, Macaya C, Lopez-Sendon JL. Moreno R, et al. Among authors: goicolea fj. EuroIntervention. 2010 May;6(1):112-6. EuroIntervention. 2010. PMID: 20542806 Clinical Trial.
Randomized comparison of sirolimus-eluting and everolimus-eluting coronary stents in the treatment of total coronary occlusions: results from the chronic coronary occlusion treated by everolimus-eluting stent randomized trial.
Moreno R, García E, Teles R, Rumoroso JR, Cyrne Carvalho H, Goicolea FJ, Moreu J, Mauri J, Sabaté M, Mainar V, Patricio L, Valdés M, Fernández Vázquez F, Sánchez-Recalde A, Galeote G, Jimenez-Valero S, Almeida M, Lopez de Sa E, Calvo L, Plaza I, Lopez-Sendón JL, Martín JL; CIBELES Investigators. Moreno R, et al. Among authors: goicolea fj. Circ Cardiovasc Interv. 2013 Feb;6(1):21-8. doi: 10.1161/CIRCINTERVENTIONS.112.000076. Epub 2013 Feb 12. Circ Cardiovasc Interv. 2013. PMID: 23403384 Clinical Trial.
Techniques and material used in the percutaneous treatment of chronic coronary occlusions. Data from the CIBELES study.
Moreno R, García E, Teles R, Rumoroso JR, Cyrne Carvalho H, Goicolea FJ, Moreu J, Mauri F, Sabaté M, Mainar V, Patricio L, Valdés M, Cuellas C, Almeida M, Sánchez-Recalde A, Galeote G, Jimenez-Valero S, Calvo L, Plaza I, Lopez-Sendón JL, Martín JL; Investigators of the CIBELES trial. Moreno R, et al. Among authors: goicolea fj. Rev Port Cardiol. 2013 Jul-Aug;32(7-8):593-9. doi: 10.1016/j.repc.2012.11.012. Epub 2013 Jul 27. Rev Port Cardiol. 2013. PMID: 23896301 Free article.
Comparison between diabetic and non-diabetic patients after successful percutaneous coronary intervention for chronic total occlusions in the drug-eluting stent era.
Ruiz-Garcia J, Teles R, Rumoroso JR, Cyrne Carvalho H, Goicolea FJ, Moreu J, Mauri J, Mainar V, García E, Moreno R; CIBELES investigators. Ruiz-Garcia J, et al. Among authors: goicolea fj. Rev Port Cardiol. 2015 Apr;34(4):263-70. doi: 10.1016/j.repc.2014.10.009. Epub 2015 Apr 1. Rev Port Cardiol. 2015. PMID: 25840644 Free article. Clinical Trial.
Age and Gender influence on time of arrival for STEMI patients during Covid-19 pandemic.
Moreno R, Alonso JJ, Caballero R, Del Corral E, Elízaga J, Asenjo RM, Mena MJ, Alfonso F, Fernández-Ortiz A, Goicolea FJ, Botas J, Navarro F, Alegría-Barrero E, Ansede JC, de Sá EL, López-Sendón JL. Moreno R, et al. Among authors: goicolea fj. Am J Emerg Med. 2021 Apr;42:244-245. doi: 10.1016/j.ajem.2020.06.013. Epub 2020 Jun 6. Am J Emerg Med. 2021. PMID: 32540217 Free PMC article. No abstract available.
Safety of intravenous ivabradine in acute ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention: a randomized, placebo-controlled, double-blind, pilot study.
Steg P, Lopez-de-Sà E, Schiele F, Hamon M, Meinertz T, Goicolea J, Werdan K, Lopez-Sendon JL; VIVIFY (eValuation of the IntraVenous If inhibitor ivabradine after STsegment elevation mYocardial infarction) investigators. Steg P, et al. Eur Heart J Acute Cardiovasc Care. 2013 Sep;2(3):270-9. doi: 10.1177/2048872613489305. Eur Heart J Acute Cardiovasc Care. 2013. PMID: 24222839 Free PMC article. Clinical Trial.
Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention.
Vaduganathan M, Harrington RA, Stone GW, Deliargyris EN, Steg PG, Gibson CM, Hamm CW, Price MJ, Menozzi A, Prats J, Elkin S, Mahaffey KW, White HD, Bhatt DL; CHAMPION Investigators. Vaduganathan M, et al. J Am Coll Cardiol. 2017 Jan 17;69(2):176-185. doi: 10.1016/j.jacc.2016.10.055. J Am Coll Cardiol. 2017. PMID: 28081827 Free article. Clinical Trial.
17 results